Back to Search
Start Over
Involvement of nitric oxide pathways in neurogenic pulmonary edema induced by vagotomy.
- Source :
-
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2011; Vol. 66 (6), pp. 1061-6. - Publication Year :
- 2011
-
Abstract
- Objective: The objective of this study was to evaluate the involvement of peripheral nitric oxide (NO) in vagotomy-induced pulmonary edema by verifying whether the nitric oxide synthases (NOS), constitutive (cNOS) and inducible (iNOS), participate in this mechanism.<br />Introduction: It has been proposed that vagotomy induces neurogenic pulmonary edema or intensifies the edema of other etiologies.<br />Methods: Control and vagotomized rats were pretreated with 0.3 mg/kg, 3.0 mg/kg or 39.0 mg/kg of L-NAME, or with 5.0 mg/kg, 10.0 mg/kg or 20.0 mg/kg of aminoguanidine. All animals were observed for 120 minutes. After the animals' death, the trachea was catheterized in order to observe tracheal fluid and to classify the severity of pulmonary edema. The lungs were removed and weighed to evaluate pulmonary weight gain and edema index.<br />Results: Vagotomy promoted pulmonary edema as edema was significantly higher than in the control. This effect was modified by treatment with L-NAME. The highest dose, 39.0 mg/kg, reduced the edema and prolonged the survival of the animals, while at the lowest dose, 0.3 mg/kg, the edema and reduced survival rates were maintained. Aminoguanidine, regardless of the dose inhibited the development of the edema. Its effect was similar to that observed when the highest dose of L-NAME was administered. It may be that the non-selective blockade of cNOS by the highest dose of L-NAME also inhibited the iNOS pathway.<br />Conclusion: Our data suggest that iNOS could be directly involved in pulmonary edema induced by vagotomy and cNOS appears to participate as a protector mechanism.
- Subjects :
- Animals
Enzyme Inhibitors therapeutic use
Guanidines therapeutic use
Male
NG-Nitroarginine Methyl Ester therapeutic use
Nitric Oxide Synthase Type II antagonists & inhibitors
Nitric Oxide Synthase Type III antagonists & inhibitors
Pulmonary Edema drug therapy
Pulmonary Edema etiology
Pulmonary Edema prevention & control
Rats
Rats, Wistar
Severity of Illness Index
Time Factors
Nitric Oxide metabolism
Nitric Oxide Synthase Type II metabolism
Nitric Oxide Synthase Type III metabolism
Pulmonary Edema metabolism
Vagotomy adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1980-5322
- Volume :
- 66
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Clinics (Sao Paulo, Brazil)
- Publication Type :
- Academic Journal
- Accession number :
- 21808876
- Full Text :
- https://doi.org/10.1590/s1807-59322011000600024